Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. DEST.L Share Price
  4. DEST.L Share Regulatory News
  5. Cancellation - Destiny Pharma plc

Pin to quick picksDEST.L Regulatory News (DEST)

DEST.L Information
  • There is currently no data for DEST

Cancellation - Destiny Pharma plc

13 Aug 2024 07:00

RNS Number : 1374A
AIM
13 August 2024
 

NOTICE

 

13/08/2024 - 07:00

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

 

At the request of the company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 

DESTINY PHARMA PLC

213800O9WH9Z38EHAC95

ORDINARY SHARES OF GBP0.01 EACH, FULLY PAID

(BDHSP57)(GB00BDHSP575)

DESY PHAR/PAR VTG FPD 0.01

 

If you have any queries or require further information, please contact the company's nominated adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AMOBSGDIISBDGSD
123456
Date   Source Headline
13th Aug 20247:00 amRNSCancellation - Destiny Pharma plc
12th Aug 20247:00 amRNSLast Day of Dealings on AIM
5th Aug 202411:58 amRNSDirector/PDMR Shareholding
31st Jul 202411:00 amRNSResult of GM and Cancellation of Trading on AIM
15th Jul 20247:00 amRNSProposed Cancellation of Admission to Trading
20th Jun 20247:00 amRNSExercise of Options and Total Voting Rights
18th Jun 20247:00 amRNSEfficacy of XF-70 in Fungal Skin Infections
12th Jun 202412:16 pmRNSResult of Annual General Meeting
12th Jun 202411:00 amRNS2024 Annual General Meeting and Statement
11th Jun 20247:00 amRNSDestiny Pharma's XF-73 Nasal Awarded MHRA ILAP
24th May 20247:00 amRNSExercise of Options and Total Voting Rights
9th May 20242:35 pmRNSPosting of Annual Report and Notice of AGM
25th Apr 20247:00 amRNSFull year results and review of strategic options
8th Apr 20247:00 amRNSNotice of Full Year Results
19th Mar 20242:47 pmRNSExercise of Options and Total Voting Rights
31st Jan 20247:00 amRNSClinical development update
22nd Jan 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
4th Jan 20247:00 amRNSYear End Business Update
20th Oct 20237:00 amRNSGrant of Share Options
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:01 amRNSXF Pipeline Update Meeting
17th Oct 20237:00 amRNSPublication of new microbiological data for XF-73
10th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 202312:34 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSNotice of XF Pipeline Update Meeting
20th Sep 20237:00 amRNSInterim Results
23rd Aug 20237:00 amRNSNotice of Interim Results
31st Jul 202312:01 pmRNSPublication of new data for XF-73
25th Jul 20237:00 amRNSAppointment of new Chairman
19th Jul 202312:55 pmRNSBoard changes including appointment of new CEO
7th Jul 20237:00 amRNSExercise of Options and Total Voting Rights
6th Jul 20237:00 amRNSPositive findings from recent SAB meeting
29th Jun 20237:00 amRNSBusiness Update
26th May 20233:27 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSDirector Dealing
25th May 202312:23 pmRNSResult of Annual General Meeting
25th May 20237:00 amRNSDr Debra Barker Appointed Interim CEO
12th May 202312:24 pmRNSGrant of Share Options
2nd May 20237:00 amRNSPositive results from SPOR-COV® research
26th Apr 20234:10 pmRNSPosting of Annual Report and Notice of AGM
26th Apr 202310:05 amRNSExercise of Options and Total Voting Rights
13th Apr 20237:00 amRNSAudited results for year ended 31 December 2022
4th Apr 20237:00 amRNSLandmark data published on NTCD-M3
3rd Apr 20237:00 amRNSNotice of Results and Investor Presentation
24th Mar 20237:00 amRNSLandmark XF-73 Phase 2 data published in journal
16th Mar 20233:29 pmRNSResult of General Meeting and Total Voting Rights
15th Mar 20234:02 pmRNSResult of Open Offer
6th Mar 202310:50 amRNSExercise of Options and Total Voting Rights
6th Mar 202310:31 amRNSHolding(s) in Company
28th Feb 20233:55 pmRNSPosting of Circular and Notice of General Meeting
123456

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DEST
DEST.L
LSE
0.00%
AEX
Aminex
LSE
-1.85%
FEVR
Fevertree
LSE
1.69%
ASC
ASOS
LSE
1.65%
BTG
BTG
LSE
1.60%
Trending
ITM
Itm Power
LSE
-10.85%
LLOY
Lloyds
LSE
-1.33%
PPP
Pennpetro Energy
LSE
0.00%
BEM
Beowulf Mining PLC
LSE
63.64%
NANO
Nanoco
LSE
-10.69%